The NFIB/CARM1 Partnership is a Therapeutic Target for Small Cell Lung Cancer
Ontology highlight
ABSTRACT: This project identified NFI family members as CARM1 substrates. NFIB was previously reported to play a critical role in the development of small cell lung cancer. We provided evidence that the arginine methylation of NFIB is required for its oncogenic function in small cell lung cancer.
INSTRUMENT(S): Orbitrap Fusion ETD
ORGANISM(S): Mus Musculus (ncbitaxon:10090)
SUBMITTER: Bill Russell
PROVIDER: MSV000090746 | MassIVE | Sat Nov 19 07:31:00 GMT 2022
SECONDARY ACCESSION(S): PXD038217
REPOSITORIES: MassIVE
ACCESS DATA